Advanced Multi Organ Chips Market is anticipated to expand from 1.2 billion in 2024 to 8.5 billion b
The Advanced Multi-Organ Chips Market encompasses the development and commercialization of microfluidic devices that simulate human organ systems on a chip. These innovative platforms facilitate drug discovery, disease modeling, and personalized medicine by mimicking complex physiological responses. The market is driven by advancements in biotechnology, increasing demand for alternative testing methods, and the need for more accurate preclinical models, offering substantial opportunities for growth in pharmaceutical research and development.